Welcome to the ICCS Website
The fundamental goal of the ICCS is to improve the quality of life and the life expectancy for all growing individuals with deficient bladder function, expressed as problems of storage and evacuation of urine. ICCS intends to approach this goal by increasing knowledge in all aspects of this problem area.
President's Message
Dear ICCS member
....after the summer holidays I will take the boat across the Baltic and join the ICCS conference in Gdansk, Poland, on September 12-14. We have recently reviewed the abstracts and they were mostly very fine, and our friends Michal Maternik and Rafal Chrzan have finalized a programme that promises to be both interesting and comprehensive. They will, together with the ICCS Board, make sure that everyone will learn a lot while having fun and making new friends. And drinking good Polish beer, if that's your inclination. The Kelm Hjälmås memorial lecture will be held by the well-known pediatric urologist and researcher Tom de Jong from Utrecht, the Netherlands.... More...
Abstract Deadline Extended to May 12, 2019
Registration form or registration on-line available at:
click on link to go to meeting website www.iccs2019.com
REGISTRATION FEES EARLY BIRD REGULAR ON SITE
ICCS Member Doctor 300 Euro 350 Euro 400 Euro
Non-Member Doctor 350 Euro 400 Euro 450 Euro
Nurse/Physiotherapist 250 Euro 300 Euro 350 Euro
Urodynamics /Urotherapy course 50 Euro 75 Euro 100 Euro
Organizers:
Michał Maternik
Department of Pediatrics, Nephrology and Hypertension
Medical University of Gdansk
Rafal Chrzan
Department of Pediatric Urology
Jagiellonian University in Krakow
ICCS Annual Meeting Office:
Michał Faliński
KOMBINAT Spółka z ograniczoną odpowiedzialnością Sp. k.
mfalinski@grupakombinat.pl
+ 48 600 800 916
Industry cooperation statement
The ICCS is an independent, nonprofit organisation aimed at the advancement of research and healthcare. The ICCS Board and associated experts get no payment for their work. The running costs of the ICCS are covered by membership fees and unconditional educational grants from the medical industry.
Foremost among the latter are presently two companies: Ferring Pharmaceuticals and Coloplast, the cooperation with which we hereby gratefully acknowledge. The cooperation is regulated by contracts guaranteeing the independence and protection of both parts, and all matters of common interest are handled by liaison committees, with members from the ICCS and the two companies.
The ICCS members of the ICCS-Ferring liaison committee are Janet Chase, Søren Rittig and Johan Vande Walle. The ICCS members of the ICCS-Coloplast liaison committee are Mario De Gennaro, Søren Rittig and Anka Nieuwhof-Leppink.